OtherCHEMOTHERAPY/GENE THERAPY
Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Δ8-Δ7 Sterol Isomerase
Raymond Paul, Sandra Silve, Nathalie De Nys, Pascal-Henry Dupuy, Christine Labit-Le Bouteiller, Jorge Rosenfeld, Pascual Ferrara, Gérard Le Fur, Pierre Casellas and Gérard Loison
Journal of Pharmacology and Experimental Therapeutics June 1998, 285 (3) 1296-1302;
Raymond Paul
Sandra Silve
Nathalie De Nys
Pascal-Henry Dupuy
Christine Labit-Le Bouteiller
Jorge Rosenfeld
Pascual Ferrara
Gérard Le Fur
Pierre Casellas
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 285, Issue 3
1 Jun 1998
OtherCHEMOTHERAPY/GENE THERAPY
Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Δ8-Δ7 Sterol Isomerase
Raymond Paul, Sandra Silve, Nathalie De Nys, Pascal-Henry Dupuy, Christine Labit-Le Bouteiller, Jorge Rosenfeld, Pascual Ferrara, Gérard Le Fur, Pierre Casellas and Gérard Loison
Journal of Pharmacology and Experimental Therapeutics June 1, 1998, 285 (3) 1296-1302;
OtherCHEMOTHERAPY/GENE THERAPY
Both the Immunosuppressant SR31747 and the Antiestrogen Tamoxifen Bind to an Emopamil-Insensitive Site of Mammalian Δ8-Δ7 Sterol Isomerase
Raymond Paul, Sandra Silve, Nathalie De Nys, Pascal-Henry Dupuy, Christine Labit-Le Bouteiller, Jorge Rosenfeld, Pascual Ferrara, Gérard Le Fur, Pierre Casellas and Gérard Loison
Journal of Pharmacology and Experimental Therapeutics June 1, 1998, 285 (3) 1296-1302;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement